CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study.

Jose D Tovar-ParraLuz Dary Castañeda-CastañedaSebastián R Gil-QuiñonesJhon A NovaLeonardo Pulido

Published in: BioMed research international (2020)

CDKN2A polymorphisms p.G101W, p.R24P, p.M53I, and A148T are not associated with melanoma susceptibility in the Colombian population; further studies regarding genetic interaction and additive effects between more variants are required.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
genome wide
patient reported outcomes
case control
patient reported